Magnetic Resonance Characteristics and Susceptibility Weighted Imaging of the Brain in Gadolinium Encephalopathy

Journal of Neuroimaging

Volumn 25, Issue 1, 2015, Pages 136-139

  Samardzic, Dejan ^a   Thamburaj, Krishnamoorthy ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Gadolinium encephalopathy; Intrathecal gadolinium; Subarachnoid hemorrhage; Susceptibility weighted imaging

Indexed keywords

DEXAMETHASONE; GADOLINIUM; TRIAMCINOLONE; CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE;

AGED; ARTICLE; BRAIN DISEASE; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID; CHILL; DRUG DIFFUSION; DRUG MEGADOSE; DYSPNEA; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; NAUSEA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; SUBARACHNOID HEMORRHAGE; SUSCEPTIBILITY WEIGHTED IMAGING; ADVERSE EFFECTS; BRAIN; CHEMICALLY INDUCED; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECTS; PATHOLOGY; PROCEDURES;

AGED; BRAIN; BRAIN DISEASES; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84920943662     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12067     Document Type: Article

References (13)

1. Safriel Y, Ali M, Hayt M, et al. Gadolinium use in spine procedures for patients with allergy to iodinated contrast-experience of 127 procedures. AJNR Am J Neuroradiol 2006;27:1194-1197.
2. Shetty SK, Nelson EN, Lawrimore TM, et al. Use of gadolinium chelate to confirm epidural needle placement in patients with an iodinated contrast reaction. Skeletal Radiol 2007;36:301-307.
3. Maramattom BV, Manno EM, Wijdicks EFM, et al. Gadolinium encephalopathy in a patient with renal failure. Neurology 2005;64:1276-1278.
4. Arlt S, Cepek L, Rustenbeck HH, et al. Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine. J Neurol 2007;254:810-812.
5. Zeng Q, Xiong L, Jinkins JR, et al. Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients. AJR Am J Roentgenol 1999;173:1109-1115.
6. Tali ET, Ercan N, Krumina G, et al. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study. Invest Radiol 2002;37:152-159.
7. Algin O, Turkbey B. Intrathecal gadolinium-enhanced MR cisternography: a comprehensive review. AJNR Am J Neuroradiol 2013;34:14-22.
8. Li L, Gao FQ, Zhang B, et al. Overdosage of intrathecal gadolinium and neurological response. Clin Radiol 2008;63:1063-1068.
9. Jinkins JR, Williams RF, Xiong L. Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: preliminary report. Invest Radiol 1999;34:156-159.
10. Kapoor R, Liu J, Devasenapathy A, et al. Gadolinium encephalopathy after intrathecal gadolinium injection. Pain Physician 2010;13:E321-E326.
11. Ray DE, Cavanagh JB, Nolan CC, et al. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats. AJNR Am J Neuroradiol 1996;17:365-373.
12. Ray DE, Holton JL, Nolan CC, et al. Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol 1998;19:1455-1462.
13. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19-30.